top of page

PSSD Suomi

This site was created to promote the issues and the improvement of the status of PSSD patients. The disease has reached very poor awareness among both the media and the medical community in Finland.

In 2019, the European Medicines Agency acknowledged that sexual dysfunction may persist after discontinuing SSRIs and SNRIs. So far, only persistent sexual symptoms have been officially recognized, but numerous other symptoms reported by affected individuals have yet to receive official acknowledgment.

bottom of page